Why the study?
Early microsurgical clipping is recommended to prevent rebleeding in ruptured intracranial aneurysms, but management dilemmas arise in patients with current aspirin use.
Does long-term aspirin use increase bleeding complications or worsen outcomes in patients undergoing early microsurgical clipping for ruptured intracranial aneurysms?
Does long-term aspirin use increase bleeding complications or worsen outcomes in patients undergoing early microsurgical clipping for ruptured intracranial aneurysms?
Long-term low-dose aspirin use is not associated with increased bleeding risks or worse functional outcomes in patients undergoing early microsurgical clipping for ruptured intracranial aneurysms.
May support early clipping despite aspirin in aSAH; leaves open prospective validation before practice change.
BACKGROUND: Early microsurgical clipping is recommended for ruptured intracranial aneurysms to prevent rebleeding. However, dilemma frequently occurs when managing patients with current acetylsalicylic acid (aspirin) use. This study aimed to examine whether aspirin use was associated with worse outcomes after early surgery for aneurysmal subarachnoid hemorrhage (aSAH). METHODS: We retrieved a consecutive series of 215 patients undergoing early microsurgical clipping within 72 h after aneurysmal rupture from 2012 to 2018 in the neurosurgery department of Beijing Tiantan Hospital. The medical records of each case were reviewed. Twenty-one patients had a history of long-term aspirin use before the onset of aSAH, and 194 patients did not. To reduce confounding bias, propensity score matching (PSM) was performed to balance some characteristics of the two groups. The intraoperative blood loss, postoperative hemorrhagic events, postoperative hospital stay, and functional outcome at discharge were compared between aspirin and non-aspirin group. RESULTS: We matched all the 21 patients in aspirin group with 42 patients in non-aspirin group (1:2). Potential confounding factors were corrected between the two groups by PSM. No hospital mortality occurred after surgery. No significant differences were found in intraoperative blood loss (P = 0.540), postoperative hemorrhagic events (P > 0.999), postoperative hospital stay (P = 0.715), as well as functional outcome at discharge (P = 0.332) between the two groups. CONCLUSIONS: Our preliminary results showed that long-term low-dose aspirin use was not associated with worse outcomes. Early surgery can be safe for ruptured intracranial aneurysms in patients with long-term aspirin use.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: